MX348898B - Métodos y composiciones para tratar, reducir, o prevenir el deterioro del sistema visual de los animales. - Google Patents

Métodos y composiciones para tratar, reducir, o prevenir el deterioro del sistema visual de los animales.

Info

Publication number
MX348898B
MX348898B MX2013008729A MX2013008729A MX348898B MX 348898 B MX348898 B MX 348898B MX 2013008729 A MX2013008729 A MX 2013008729A MX 2013008729 A MX2013008729 A MX 2013008729A MX 348898 B MX348898 B MX 348898B
Authority
MX
Mexico
Prior art keywords
methods
compositions
visual system
treating
reducing
Prior art date
Application number
MX2013008729A
Other languages
English (en)
Other versions
MX2013008729A (es
Inventor
Pan Yuanlong
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2013008729A publication Critical patent/MX2013008729A/es
Publication of MX348898B publication Critical patent/MX348898B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

La presente invención se refiere a métodos y composiciones para tratar, reducir o prevenir el deterioro de al menos un componente del sistema visual de un animal. Los métodos comprenden administrar al animal una composición que comprende AGI y CLON en una cantidad eficaz para tratar, reducir o prevenir el deterioro de al menos un componente del sistema visual. También se describen los métodos para prolongar los años de plenitud de la vida de un animal, mejorar la calidad de vida y fomentar la salud y el bienestar de un animal, utilizando composiciones que comprenden los AGI y CLON.
MX2013008729A 2011-01-25 2012-01-24 Métodos y composiciones para tratar, reducir, o prevenir el deterioro del sistema visual de los animales. MX348898B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161461913P 2011-01-25 2011-01-25
PCT/US2012/022297 WO2012103049A1 (en) 2011-01-25 2012-01-24 Methods and compositions for treating, reducing or preventing deterioration of the visual system of animals

Publications (2)

Publication Number Publication Date
MX2013008729A MX2013008729A (es) 2013-08-14
MX348898B true MX348898B (es) 2017-07-03

Family

ID=46581129

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013008729A MX348898B (es) 2011-01-25 2012-01-24 Métodos y composiciones para tratar, reducir, o prevenir el deterioro del sistema visual de los animales.

Country Status (12)

Country Link
US (1) US9320759B2 (es)
EP (1) EP2667882B1 (es)
JP (1) JP2014504605A (es)
CN (1) CN103442725A (es)
AU (1) AU2012209285B2 (es)
BR (1) BR112013018839A2 (es)
CA (1) CA2825022A1 (es)
ES (1) ES2828479T3 (es)
MX (1) MX348898B (es)
RU (1) RU2597793C2 (es)
WO (1) WO2012103049A1 (es)
ZA (1) ZA201306388B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112016014182A2 (pt) * 2013-12-19 2017-08-08 Georgiou Tassos Composições de ácidos graxos ômega 3 para tratar doenças que envolvem danos ao sistema nervoso
RU2016127357A (ru) * 2013-12-19 2018-01-24 Ф. Хоффманн-Ля Рош Аг Модулятор сетр для применения в лечении заболеваний глаз
MX2017004662A (es) * 2014-10-10 2017-07-26 Nestec Sa Composiciones y metodos para mejorar la movilidad o actividad o tratar la fragilidad.
RU2632958C2 (ru) * 2015-10-20 2017-10-11 федеральное государственное бюджетное образовательное учреждение высшего образования "Алтайский государственный технический университет им. И.И. Ползунова" (АлтГТУ) Сироп бальзамный для профилактики потери остроты зрения
US20170173138A1 (en) * 2015-12-22 2017-06-22 Nestec Sa Immune health for companion animals
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
CN106689960A (zh) * 2017-01-11 2017-05-24 珠海市御得养生食品研究院有限公司 一种保护视力固体饮料
CN111295187A (zh) 2017-08-14 2020-06-16 胺细拉健康公司 用于治疗肝脏疾病的氨基酸组合物
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
US11696593B2 (en) 2018-08-24 2023-07-11 Bioscience Formulators, LLC Astaxanthin nutritional compositions and uses
WO2023278181A1 (en) * 2021-06-28 2023-01-05 DailyColors Health Inc. Compositions and methods to counteract processes associated with inflammation and senescence and to support cellular energy and/or metabolism
WO2023183212A1 (en) * 2022-03-22 2023-09-28 Ark Naturals Company Edible soft dental chew and methods of using the same

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952033A (en) 1996-12-24 1999-09-14 Nestec S.A. Gelatinized cereal product containing oligosaccharide and processes of preparing and using same
ATE206873T1 (de) 1997-01-09 2001-11-15 Nestle Sa Probiotik enthaltendes getreideprodukt
CA2383714C (en) 1999-09-07 2009-05-12 Societe Des Produits Nestle S.A. Method for improving the skin and coat of pets
WO2001021008A2 (en) 1999-09-22 2001-03-29 Societe Des Produits Nestle S.A. Method for increasing pet activity
ES2284089T3 (es) 2000-05-25 2007-11-01 Societe Des Produits Nestle S.A. Probioticos para aplicaciones en alimentos para animales domesticos.
DE60122523T2 (de) 2000-05-26 2007-05-03 Société des Produits Nestlé S.A. Futter für haustiere
GB0027761D0 (en) 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
EP1344458A1 (en) 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system
WO2005110375A1 (en) * 2004-05-08 2005-11-24 Paul Edward L Jr Nutritional supplement for treatment of ocular diseases
US20060046982A1 (en) 2004-08-26 2006-03-02 Waugh William H Orthomolecular medical use of L-citrulline for capillary endothelial protection and adjacent cell protection in neurodegenerative disease
US20060088574A1 (en) 2004-10-25 2006-04-27 Manning Paul B Nutritional supplements
MX2008002623A (es) * 2005-08-26 2008-03-18 Nestec Sa Composiciones y metodos para mejorar la integridad vascular funcional, la supervivencia celular y para reducir la apoptosis en isquemia o despues de un episodio isquemico en el cerebro.
AU2006299665B2 (en) 2005-09-30 2012-12-13 Nestec S.A. Methods and compositions for improving cognitive function
WO2008143642A2 (en) 2006-11-09 2008-11-27 Children's Medical Center Corporation Methods of treating and preventing ocular neovascularization with omega-3 polyunsaturated fatty acids
AU2008307494B2 (en) 2007-10-04 2013-09-05 Société des Produits Nestlé S.A. Compositions and methods for enhancing cognitive function
US20090110674A1 (en) * 2007-10-24 2009-04-30 Loizou Nicos C Health supplement
BRPI0820802A2 (pt) * 2007-12-17 2015-06-16 Univ Florida Materiais e métodos para tratamento de proliferação vascular ocular patológica
CN105267969A (zh) * 2008-01-04 2016-01-27 雀巢产品技术援助有限公司 包含不饱和脂肪酸和一氧化氮释放化合物的组合物及其用于增强认知和相关功能的用途
US20090325999A1 (en) * 2008-06-27 2009-12-31 Jie Du Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions
WO2010074940A1 (en) 2008-12-23 2010-07-01 Alcon Research, Ltd. Compositions and nutritional supplements for improving ocular health and reducing ocular inflammatory response
BRPI0924012A2 (pt) 2009-04-17 2019-09-24 Cela Vista Pharmaceuticals Ltd processo para obtenção de uma composição rica em ácidos graxos ômega 3 de um óleo de origem marinha, com um teor de af interior 90 mg/g composição, suplemento nutricional produto alimentar, composição farmacêutica, e, uso de um composto
US20110208153A1 (en) * 2010-02-24 2011-08-25 John Alvey Formulations and methods for nutrient delivery

Also Published As

Publication number Publication date
US20130309329A1 (en) 2013-11-21
RU2013139430A (ru) 2015-03-10
EP2667882A1 (en) 2013-12-04
ES2828479T3 (es) 2021-05-26
AU2012209285A1 (en) 2013-08-01
CA2825022A1 (en) 2012-08-02
WO2012103049A1 (en) 2012-08-02
MX2013008729A (es) 2013-08-14
AU2012209285B2 (en) 2016-11-17
CN103442725A (zh) 2013-12-11
ZA201306388B (en) 2015-03-25
BR112013018839A2 (pt) 2016-09-27
JP2014504605A (ja) 2014-02-24
EP2667882A4 (en) 2014-06-25
US9320759B2 (en) 2016-04-26
EP2667882B1 (en) 2020-08-12
RU2597793C2 (ru) 2016-09-20

Similar Documents

Publication Publication Date Title
MX348898B (es) Métodos y composiciones para tratar, reducir, o prevenir el deterioro del sistema visual de los animales.
WO2012112340A3 (en) Methods and compositions for treating, reducing, or preventing damage to the nervous system of animals
MX2009011898A (es) Composiciones y metodos para tratar trastornos asociados con retencion de sal o fluido.
MX362974B (es) Compuestos para el tratamiento de alteraciones neuropsiquiatricas.
PH12014502698B1 (en) Improved antagonist antibodies against gdf-8 and uses therefor
MY153948A (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
BR112012021905A2 (pt) tratamento de nefrite lúpica usando laquinimod
MX351670B (es) Bacteria bacillus para uso en tratar y prevenir infecciones en animales acuaticos.
MX2013007189A (es) Metodos y composiciones adecuados para manejar glucosa en sangre en animales.
EP2294184A4 (en) TREATMENT OF EYE DISEASES AND EXCESSIVE NEOVASCULARIZATION WITH THE HELP OF COMBINED THERAPY
MY150602A (en) Subtituted-quinoxaline-type piperidine compounds and the uses thereof
MY169328A (en) Compositions for the treatment of dry eye
NZ602478A (en) Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate
MX342001B (es) Tratamiento de artritis por lupus usando laquinimod.
WO2015157559A3 (en) 10',11'-modified saxitoxins useful for the treatment of pain
MX363465B (es) Tratamiento de la grasa submental.
NZ597031A (en) Perhexiline for use in the treatment of hypertrophic cardiomyopathy (hcm)
AU2016216741A1 (en) Compositions and methods of use of an inappetance-controlling compound
DK2714888T3 (da) Rekombinant gær
EP2490700A4 (en) EXTERNAL SKIN CARE COMPOSITION COMPRISING SALT AND SUGAR AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING VAGINOSIS AND USE THEREOF
EA201200428A1 (ru) Композиция и способ для лечения ожирения
MX2011012310A (es) Tratamiento de insuficiencia cardiaca con fracción de eyeccion normal (icfen).
WO2011153377A3 (en) Methods and compositions for treating a subject for central nervous system (cns) injury
MX347263B (es) Metodos para incrementar la produccion o actividad de catalasa.
ATE538799T1 (de) Zusammensetzungen zur behandlung von haarverlust

Legal Events

Date Code Title Description
FG Grant or registration